Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES TOBII IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM
Mandate

VINGE ADVISES TOBII IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

April 28, 2015

Vinge advises Tobii AB (publ) in connection with Tobii’s listing on Nasdaq Stockholm.

Tobii is the global leader in eye tracking, a technology that is used to gain insights in human behavior or as a means to interact with computers and other devices. The Swedish language prospectus was published on 13 April 2015 and the first day of trading was 24 April 2015. The offering price has been set at SEK 25 per share, corresponding to a market value of Tobii of approximately SEK 2.1 billion.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Winnerblad, Rikard Lindahl, Charlotta Järnstedt and Henrik Wastenson.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026